Roching Holdings (SWX: RO), a Swiss developer of pharmaceutical and therapeutic medicines used in oncology, has agreed to acquire Ignyta (NASDAQ: RXRX), a US developer of personalized-medicine therapies designed for autoimmune diseases.
0 Comments
Kindred Healthcare (NYSE: KND) will be acquired for $9.00 per share in cash by Humana (NYSE: HUM), TPG Capital, and Welsh, Carson, Anderson & Stowe (“WCAS”). The total consideration equates to approximately $4.1 billion.
UnitedHealth Group (NYSE: UNH) announced it will purchase the primary and urgent care unit of DaVita (NYSE: DVA) for $4.9 billion.
|
Archives
March 2019
Categories |